The stromal PDGFR signaling is associated with poor prognosis of breast cancer [64] and blocking stromal PDGFR activation impaired tumor progression in genetically engineered mouse model of cervical carcinogenesis [65]. This evidence concerns the gene PDGFRB and breast cancer.